Bath & Body Works (NYSE:BBWI) Issues FY 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share guidance of 3.250-3.600 for the period, compared to the consensus earnings per share estimate of 3.520. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.5 billion. Bath & Body Works also updated its Q1 2025 guidance to 0.490-0.490 EPS.

Analyst Ratings Changes

A number of brokerages recently weighed in on BBWI. Raymond James lowered their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating on the stock in a report on Thursday, April 17th. Wells Fargo & Company upped their target price on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an “overweight” rating in a report on Wednesday, May 14th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an “overweight” rating in a research report on Thursday. Telsey Advisory Group reiterated an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, The Goldman Sachs Group decreased their target price on Bath & Body Works from $49.00 to $42.00 and set a “buy” rating on the stock in a report on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and an average price target of $42.06.

Bath & Body Works Trading Down 0.6%

Shares of BBWI stock opened at $33.56 on Tuesday. The stock has a market cap of $7.15 billion, a P/E ratio of 8.19, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. Bath & Body Works has a 1 year low of $24.96 and a 1 year high of $52.99. The stock has a 50 day simple moving average of $30.05 and a 200 day simple moving average of $34.03.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. Analysts forecast that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date of this dividend is Friday, June 6th. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works declared that its Board of Directors has initiated a share repurchase plan on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in BBWI. Royal Bank of Canada raised its holdings in shares of Bath & Body Works by 92.8% during the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after buying an additional 28,815 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Bath & Body Works by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after acquiring an additional 36,684 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in Bath & Body Works by 15.7% during the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after acquiring an additional 87,529 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.